Skip to content
Research Article Open access CC BY 3.0

Gut Uptake, Brain and Behaviour

Tveiten D. Bioeng, K. L. Reichelt

Journal of Scientific Research and Reports · pp. 2834–2847 · Published 6 Sep 2014

10.9734/JSRR/2014/10162

Abstract

Aims: To document the evidence for a gut uptake to brain axis. The many hormones, many of them peptides and shared by the intestines and the brain, will not be included in this survey. Methods: Systematic looking through journal publications by means of Pub med and collected information and authors research since 1978. Results: Food-protein antibodies, food-protein derived peptides and direct physiological evidence point to considerable effect of the digestive system on behavior and mood. Removal of specific proteins from diet ameliorates the clinical condition. Conclusion: Uptake from the gut of various substances has effect on behaviour.

Gut uptake antibodies peptides behaviour

References (97)

  1. 1 Coeliac disease: dissecting a complex inflammatory disorder [DOI]
  2. 2 Gastrointestinal abnormalities in children with autistic disorder [DOI]
  3. 3 Abnormal intestinal permeability in children with autism [DOI]
  4. 4 Coeliac disease, epilepsy, and cerebral calcifications [DOI]
  5. 5 Casein peptide release and passage to the blood in humans during digestion of milk or yogurt [DOI]
  6. 6 A Randomised, Controlled Study of Dietary Intervention in Autistic Syndromes [DOI]
  7. 7 The ScanBrit randomised, controlled, single-blind study of a gluten- and casein-free dietary intervention for children with autism spectrum disorders [DOI]
  8. 8 Inflammatory Bowel Disease: A Study of the Association between Anxiety and Depression, Physical Morbidity, and Nutritional Status [DOI]
  9. 9 Innate Immunity Associated with Inflammatory Responses and Cytokine Production against Common Dietary Proteins in Patients with Autism Spectrum Disorder [DOI]
  10. 10 Food allergy and infantile autism.
  11. 11 Can the Pathophysiology of Autism be Explained by the Nature of the Discovered Urine Peptides? [DOI]
  12. 12 Long-term persistence of vaccine-derived aluminum hydroxide is associated with chronic cognitive dysfunction [DOI]
  13. 13 Loosening tight junctions. Lessons from the intestine. [DOI]
  14. 14 The Passage of Maternal Dietary Proteins into Human Breast Milk [DOI]
  15. 15 Wheat Gluten as a Pathogenic Factor in Schizophrenia [DOI]
  16. 16 Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism [DOI]
  17. 17 Passage of Undegraded Dietary Antigen into the Blood of Healthy Adults [DOI]
  18. 18 Passage of Gliadin into Human Breast Milk [DOI]
  19. 19 Psychic Disturbances in Adult Coeliac Disease [DOI]
  20. 20 β-Casomorphins-7 in infants on different type of feeding and different levels of psychomotor development [DOI]
  21. 21 The relationship between schizophrenia and irritable bowel syndrome (IBS) [DOI]
  22. 22 Specific IgA antibody increases in schizophrenia [DOI]
  23. 23 Cytokine‐Induced Alteration of the Epithelial Barrier to Food Antigens in Disease [DOI]
  24. 24 Gluten, milk proteins and autism: dietary intervention effects on behavior and peptide secretion.
  25. 25 CSF and plasma beta-casomorphin-like opioid peptides in postpartum psychosis [DOI]
  26. 26 A peptide-containing fraction in the urine of schizophrenic patients which stimulates opiate receptors and inhibits dopamine uptake [DOI]
  27. 27 Psychological illness is commonly associated with functional gastrointestinal disorders and is important to consider during patient consultation: a population-based study [DOI]
  28. 28 On the Blood‐Brain Barrier to Peptides: [3H]βCasomorphin‐5 Uptake by Eighteen Brain Regions In Vivo [DOI]
  29. 29 Gluten Sensitivity in Multiple Sclerosis [DOI]
  30. 30 Antibodies to wheat gliadin in blood of psychiatric patients: possible role of emotional factors.
  31. 31 Topographic mapping of brain electrical activity in children with food-induced attention deficit hyperkinetic disorder [DOI]
  32. 32 CSF levels of receptor-active endorphins in schizophrenic patients: Correlations with symptomalogy and monoamine metabolites [DOI]
  33. 33 Possible immunological disorders in autism: concomitant autoimmunity and immune tolerance.
  34. 34 Immune activation by casein dietary antigens in bipolar disorder [DOI]
  35. 35 Absorption of intact morphiceptin by diisopropylfluorophosphate-treated rabbit ileum [DOI]
  36. 36 EXTRAPYRAMIDAL MOTOR‐DISTURRANCES IN DEMENTIA PRAECOX1) [DOI]
  37. 37 Casomorphins reduce separation distress in chicks [DOI]
  38. 38 A peptide-containing fraction of plasma from schizophrenic patients which binds to opiate receptors and induces hyper-reactivity in rats [DOI]
  39. 39 The inhibition of intestinal dipeptidylaminopeptidase-IV promotes the absorption of enterostatin and des-arginine-enterostatin across rat jejunum in vitro [DOI]
  40. 40 Towards a possible aetiology for depressions? [DOI]
  41. 41 The aluminum-induced increase in blood-brain barrier permeability to delta-sleep-inducing peptide occurs throughout the brain and is independent of phosphorus and acetylcholinesterase levels [DOI]
  42. 42 Reactive Hypoglyceinic Tendency among Habitually Violent Offenders [DOI]
  43. 43 Peptides readily penetrate the blood-brain barrier: Uptake of peptides by synaptosomes is passive [DOI]
  44. 44 P art X. P otential R ole of E ndogenous O pioids in S chizophrenia and A ffective D isorders : DEPRESSIVE PHENOMENOLOGY AND LEVELS OF CEREBROSPINAL FLUID ENDORPHINS* [DOI]
  45. 45 Determination of ophidine in human urine [DOI]
  46. 46 The relation between the psychological functioning of children with Down syndrome and their urine peptide levels and levels of serum antibodies to food proteins [DOI]
  47. 47 Ad/Hd: Possible Diagnosis And Treatment [DOI]
  48. 48 Peptide-containing fractions in depression [DOI]
  49. 49 Zonulin and Its Regulation of Intestinal Barrier Function: The Biological Door to Inflammation, Autoimmunity, and Cancer [DOI]
  50. 50 Gastrointestinal inflammation and associated immune activation in schizophrenia [DOI]
  51. 51 The humoral response in the pathogenesis of gluten ataxia [DOI]
  52. 52 Are Anxiety and Depression Related to Gastrointestinal Symptoms in the General Population? [DOI]
  53. 53 Effects of a restricted elimination diet on the behaviour of children with attention-deficit hyperactivity disorder (INCA study): a randomised controlled trial [DOI]
  54. 54 Effectiveness of the gluten-free, casein-free diet for children diagnosed with autism spectrum disorder: Based on parental report [DOI]
  55. 55 Autism and Schizophrenia: Intestinal Disorders [DOI]
  56. 56 Markers of Gluten Sensitivity and Celiac Disease in Recent-Onset Psychosis and Multi-Episode Schizophrenia [DOI]
  57. 57 Novel immune response to gluten in individuals with schizophrenia [DOI]
  58. 58 CONTROLLED TRIAL OF OLIGOANTIGENIC TREATMENT IN THE HYPERKINETIC SYNDROME [DOI]
  59. 59 Enterocolitis in children with developmental disorders [DOI]
  60. 60 Prevalence of Psychiatric Disorders in Patients with Irritable Bowel Syndrome [DOI]
  61. 61 25 Years since the discovery of presynaptic receptors: present knowledge and future perspectives [DOI]
  62. 62 Peptide transport systems for opiates across the blood-brain barrier [DOI]
  63. 63 Relapsed Schizophrenics: Earlier Discharge from the Hospital After Cereal-Free, Milk-Free Diet [DOI]
  64. 64 Porphyrinuria in childhood autistic disorder: Implications for environmental toxicity [DOI]
  65. 65 Immune Response to Dietary Proteins, Gliadin and Cerebellar Peptides in Children with Autism [DOI]
  66. 66 Focal white-matter lesions in brain of patients with inflammatory bowel disease [DOI]
  67. 67 Gluten-free diet may alleviate depressive and behavioural symptoms in adolescents with coeliac disease: a prospective follow-up case-series study [DOI]
  68. 68 Autistic Syndromes and Diet: a follow‐up study [DOI]
  69. 69 Prevalence of IgA-Antigliadin Antibodies and IgA-Antiendomysium Antibodies Related to Celiac Disease in Children With Down Syndrome [DOI]
  70. 70 β-Casomorphin Induces Fos-Like Immunoreactivity in Discrete Brain Regions Relevant to Schizophrenia and Autism [DOI]
  71. 71 Mental Disorders in Adolescents With Celiac Disease [DOI]
  72. 72 Antibodies against Food Antigens in Patients with Autistic Spectrum Disorders [DOI]
  73. 73 Peptides’ role in autism with emphasis on exorphins [DOI]
  74. 74 A Study of Circulating Gliadin Antibodies in Schizophrenia Among a Chinese Population [DOI]
  75. 75 Association between bovine casein antibody and new onset schizophrenia among US military personnel [DOI]
  76. 76 Bovine β‐Lactoglobulin in the Human Milk [DOI]
  77. 77 Passage of cows' milk protein in breast milk [DOI]
  78. 78 The concept of entero‐colonic encephalopathy, autism and opioid receptor ligands [DOI]
  79. 79 A Peptide Found in Schizophrenia and Autism Causes Behavioral Changes in Rats [DOI]
  80. 80 Dietary intervention in autistic syndromes.
  81. 81 Heat Shock Protein and Gliadin Peptide Promote Development of Peptidase Antibodies in Children with Autism and Patients with Autoimmune Disease [DOI]
  82. 82 IgA antibodies against gliadin and gluten in multiple sclerosis [DOI]
  83. 83 Higher Plasma Concentration of Food-Specific Antibodies in Persons With Autistic Disorder in Comparison to Their Siblings [DOI]
  84. 84 Dietary antigens, epitope recognition, and immune complex formation in recent onset psychosis and long-term schizophrenia [DOI]
  85. 85 Brain Effects of Chronic IBD in Areas Abnormal in Autism and Treatment by Single Neuropeptides Secretin and Oxytocin [DOI]
  86. 86 Immunological Studies of Patients with Down's Syndrome [DOI]
  87. 87 Neutral endopeptidase inhibition increases the urinary excretion and plasma levels of endothelin [DOI]
  88. 88 Immunoreactiveβ-Casomorphin-8 in Cerebrospinal Fluid From Pregnant and Lactating Women: Correlation With Plasma Levels* [DOI]
  89. 89 Elevated opioid activity in sera of chronic schizophrenics.
  90. 90 Urinary peptide levels in women with eating disorders. A pilot study [DOI]
  91. 91 Celiac Disease in Down's Syndrome with HLA Serological and Molecular Studies [DOI]
  92. 92 Urinary Peptides in Rett Syndrome [DOI]
  93. 93 Peptide Excretion in Celiac Disease [DOI]
  94. 94 Increased excretion of proline-containing peptides in dipeptidyl peptidase IV-deficient rats.
  95. 95 Down's Syndrome: Nutritional Intervention [DOI]
  96. 96 Increased levels of antibodies to food proteins in Down syndrome [DOI]
  97. 97 Brain white-matter lesions in inflammatory bowel disease [DOI]

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

69

Page views

0

PDF downloads

24

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.